Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.
Tagged double patenting · clear
Term Act Seeks to Add New Bio/Pharma Litigation Hurdle It was easy to miss last week’s introduction of a new patent reform bill on the House side entitled: “Terminating the Extension of Rights Misappropriated Act of 2019” with so much…
Federal Circuit Summary Before Prost, Wallach, and Chen . Appeal from the United States District Court for the District of Delaware. Summary : A post-URAA patent that issues after but expires before a related pre-URAA patent is not a double-patenting…
Federal Circuit Summary Before Moore, Chen , and Hughes. Appeal from the United States District Court for the District of Delaware. Summary : Obviousness-type double patenting does not invalidate an otherwise validly obtained patent term extension under 35…
